Anna Rubartelli Selected Research

3- mercapto- 3,3- cyclopentamethylenepropionic acid

3/2013

The pharmacologic inhibition of the xc- antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Rubartelli Research Topics

Disease

22	Inflammation (Inflammations) 10/2022 - 10/2002
15	Neoplasms (Cancer) 01/2022 - 03/2002
5	Cryopyrin-Associated Periodic Syndromes 01/2020 - 09/2007
3	Melanoma (Melanoma, Malignant) 09/2017 - 05/2007
3	Carcinoma (Carcinomatosis) 10/2008 - 04/2002
2	Sepsis (Septicemia) 01/2020 - 05/2007
2	Amyloid Plaque 01/2020 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 09/2017 - 03/2013
2	Arthritis (Polyarthritis) 01/2016 - 05/2007
2	Autoimmune Diseases (Autoimmune Disease) 09/2012 - 06/2004
2	Necrosis 10/2010 - 10/2009
1	Critical Illness (Critically Ill) 10/2022
1	COVID-19 10/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021
1	Neuroblastoma 12/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Amyloidosis 01/2020
1	Atherosclerosis 01/2019
1	Rheumatoid Arthritis 01/2018
1	Fibrosarcoma 01/2017
1	Starvation 01/2017
1	Acne Vulgaris 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016
1	Pyoderma Gangrenosum 01/2016
1	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2016
1	Simian Acquired Immunodeficiency Syndrome 11/2015
1	Familial Mediterranean Fever (Periodic Disease) 02/2014
1	Fever (Fevers) 02/2014
1	Carcinogenesis 03/2013
1	Muscular Atrophy (Muscle Atrophy) 10/2011

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 10/2022 - 07/2005
9	HMGB1 Protein (HMG1)IBA 01/2021 - 10/2002
7	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2002
6	InterleukinsIBA 01/2020 - 10/2002
6	AntioxidantsIBA 09/2017 - 10/2008
5	Interleukin-18 (Interleukin 18)IBA 01/2020 - 04/2002
4	InflammasomesIBA 10/2022 - 12/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 11/2011
3	NLR ProteinsIBA 10/2022 - 05/2010
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2022 - 09/2007
3	ThioredoxinsIBA 01/2020 - 10/2008
3	Pharmaceutical PreparationsIBA 09/2017 - 11/2011
3	Interleukin-1 (Interleukin 1)IBA 01/2016 - 09/2007
3	Biological ProductsIBA 10/2010 - 04/2002
3	Messenger RNA (mRNA)IBA 01/2008 - 04/2002
2	Protons (Proton)IBA 01/2022 - 09/2017
2	Protein Isoforms (Isoforms)IBA 01/2021 - 09/2004
2	AlarminsIBA 01/2021 - 03/2014
2	Immunoglobulin FragmentsIBA 01/2020 - 01/2017
2	Proton Pump InhibitorsIBA 01/2020 - 09/2017
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2017 - 03/2013
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017 - 11/2015
2	NucleotidesIBA 01/2016 - 01/2008
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2012 - 09/2007
2	Cysteine (L-Cysteine)FDA Link 11/2011 - 10/2008
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2007 - 06/2004
2	Adenosine Triphosphate (ATP)IBA 04/2006 - 10/2002
1	Hormones (Hormone)IBA 01/2022
1	AntibodiesIBA 01/2021
1	Liposomes (Liposome)IBA 12/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020
1	EnzymesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	LipidsIBA 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	dapansutrileIBA 01/2018
1	NitrilesIBA 01/2018
1	MethylcholanthreneIBA 09/2017
1	Esomeprazole (Nexium)FDA Link 09/2017
1	Adenosine Triphosphatases (ATPase)IBA 09/2017
1	Therapeutic UsesIBA 09/2017
1	Explosive Agents (Explosives)IBA 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	Mutant Proteins (Protein, Mutant)IBA 01/2017
1	Fibronectins (Fibronectin)IBA 01/2017
1	Proline (L-Proline)FDA Link 01/2016
1	Leucine (L-Leucine)FDA Link 01/2016
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2016
1	VaccinesIBA 10/2014
1	3- mercapto- 3,3- cyclopentamethylenepropionic acidIBA 03/2013
1	Ibuprofen (Motrin)FDA LinkGeneric 03/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2012
1	LipopolysaccharidesIBA 09/2012
1	Toll-Like Receptor AgonistsIBA 09/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2012
1	Cystine (L-Cystine)IBA 11/2011
1	Aligeron (AS 2)IBA 11/2011
1	UbiquitinIBA 10/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2011
1	Ligases (Synthetase)IBA 10/2011
1	Arsenic Trioxide (Trisenox)FDA Link 10/2011

Therapy/Procedure

10	Therapeutics 10/2022 - 05/2007
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Immunotherapy 01/2020